Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niacin for phosphate and PTH reduction in hemodialysis patients
IRCT20190702044076N2Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of niacin in hyperphosphatemia and chronic kidney disease (CKD) (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Level of calcium, Level of phosphate and 1 more. Started Dec 2022; status: completed.
02
Drugs
niacin
03
Conditions
hyperphosphatemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on IRCT20190702044076N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190702044076N2.